Gene symbol: Nos3

Also known as: eNos

Organism: Rattus norvegicus

Summary: Enables several functions, including Hsp90 protein binding activity; beta-catenin binding activity; and calmodulin binding activity. Involved in several processes, including cellular response to magnesium ion; cellular response to mechanical stimulus; and cellular response to organonitrogen compound. Located in several cellular components, including caveola; nucleolus; and sarcolemma. Used to study artery disease (multiple); irritable bowel syndrome; ischemia (multiple); liver disease (multiple); and retinal disease (multiple). Biomarker of several diseases, including artery disease (multiple); kidney failure (multiple); liver disease (multiple); lung disease (multiple); and overnutrition (multiple). Human ortholog(s) of this gene implicated in several diseases, including Alzheimer's disease (multiple); artery disease (multiple); eye disease (multiple); reproductive organ cancer (multiple); and vasculitis (multiple). Orthologous to human NOS3 (nitric oxide synthase 3). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 24600 Ensembl:ENSRNOG00000009348 AllianceGenome:RGD:3186


GO Annotation


Category Term ID Term description
Process GO:0000003 Reproduction
Process GO:0000302 Response to reactive oxygen species
Process GO:0000303 Response to superoxide
Process GO:0000305 Response to oxygen radical
Process GO:0001101 Response to acid chemical
Process GO:0001501 Skeletal system development
Process GO:0001525 Angiogenesis
Process GO:0001542 Ovulation from ovarian follicle
Process GO:0001568 Blood vessel development
Process GO:0001654 Eye development
Process GO:0001666 Response to hypoxia
Process GO:0001667 Ameboidal-type cell migration
Process GO:0001701 In utero embryonic development
Process GO:0001894 Tissue homeostasis
Process GO:0001944 Vasculature development
Process GO:0001974 Blood vessel remodeling
Process GO:0001990 Regulation of systemic arterial blood pressure by hormone
Process GO:0002026 Regulation of the force of heart contraction
Process GO:0002028 Regulation of sodium ion transport
Process GO:0002237 Response to molecule of bacterial origin
Process GO:0003006 Developmental process involved in reproduction
Process GO:0003007 Heart morphogenesis
Process GO:0003008 System process
Process GO:0003012 Muscle system process
Process GO:0003013 Circulatory system process
Process GO:0003018 Vascular process in circulatory system
Process GO:0003044 Regulation of systemic arterial blood pressure mediated by a chemical signal
Process GO:0003057 Regulation of the force of heart contraction by chemical signal
Process GO:0003073 Regulation of systemic arterial blood pressure
Process GO:0003100 Regulation of systemic arterial blood pressure by endothelin
Process GO:0003170 Heart valve development
Process GO:0003176 Aortic valve development
Process GO:0003177 Pulmonary valve development
Process GO:0003179 Heart valve morphogenesis
Process GO:0003180 Aortic valve morphogenesis
Process GO:0003184 Pulmonary valve morphogenesis
Process GO:0003197 Endocardial cushion development
Process GO:0003203 Endocardial cushion morphogenesis
Process GO:0003205 Cardiac chamber development
Process GO:0003206 Cardiac chamber morphogenesis
Process GO:0003231 Cardiac ventricle development
Process GO:0003279 Cardiac septum development
Process GO:0003281 Ventricular septum development
Process GO:0006082 Organic acid metabolic process
Process GO:0006140 Regulation of nucleotide metabolic process
Process GO:0006520 Cellular amino acid metabolic process
Process GO:0006525 Arginine metabolic process
Process GO:0006527 Arginine catabolic process
Process GO:0006801 Superoxide metabolic process
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006809 Nitric oxide biosynthetic process
Process GO:0006810 Transport
Process GO:0006811 Ion transport
Process GO:0006812 Cation transport
Process GO:0006813 Potassium ion transport
Process GO:0006816 Calcium ion transport
Process GO:0006950 Response to stress
Process GO:0006979 Response to oxidative stress
Process GO:0007154 Cell communication
Process GO:0007165 Signal transduction
Process GO:0007166 Cell surface receptor signaling pathway
Process GO:0007263 Nitric oxide mediated signal transduction
Process GO:0007275 Multicellular organism development
Process GO:0007276 Gamete generation
Process GO:0007292 Female gamete generation
Process GO:0007423 Sensory organ development
Process GO:0007507 Heart development
Process GO:0007548 Sex differentiation
Process GO:0007565 Female pregnancy
Process GO:0007568 Aging
Process GO:0008015 Blood circulation
Process GO:0008016 Regulation of heart contraction
Process GO:0008152 Metabolic process
Process GO:0008217 Regulation of blood pressure
Process GO:0008285 Negative regulation of cell population proliferation
Process GO:0008406 Gonad development
Process GO:0008585 Female gonad development
Process GO:0009056 Catabolic process
Process GO:0009058 Biosynthetic process
Process GO:0009063 Cellular amino acid catabolic process
Process GO:0009064 Glutamine family amino acid metabolic process
Process GO:0009065 Glutamine family amino acid catabolic process
Process GO:0009266 Response to temperature stimulus
Process GO:0009408 Response to heat
Process GO:0009410 Response to xenobiotic stimulus
Process GO:0009605 Response to external stimulus
Process GO:0009607 Response to biotic stimulus
Process GO:0009611 Response to wounding
Process GO:0009612 Response to mechanical stimulus
Process GO:0009617 Response to bacterium
Process GO:0009628 Response to abiotic stimulus
Process GO:0009636 Response to toxic substance
Process GO:0009653 Anatomical structure morphogenesis
Process GO:0009719 Response to endogenous stimulus
Process GO:0009725 Response to hormone
Process GO:0009743 Response to carbohydrate
Process GO:0009746 Response to hexose
Process GO:0009750 Response to fructose
Process GO:0009790 Embryo development
Process GO:0009792 Embryo development ending in birth or egg hatching
Process GO:0009887 Animal organ morphogenesis
Process GO:0009888 Tissue development
Process GO:0009889 Regulation of biosynthetic process
Process GO:0009891 Positive regulation of biosynthetic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009987 Cellular process
Process GO:0009991 Response to extracellular stimulus
Process GO:0010033 Response to organic substance
Process GO:0010035 Response to inorganic substance
Process GO:0010038 Response to metal ion
Process GO:0010243 Response to organonitrogen compound
Process GO:0010288 Response to lead ion
Process GO:0010468 Regulation of gene expression
Process GO:0010562 Positive regulation of phosphorus metabolic process
Process GO:0010594 Regulation of endothelial cell migration
Process GO:0010595 Positive regulation of endothelial cell migration
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010628 Positive regulation of gene expression
Process GO:0010631 Epithelial cell migration
Process GO:0010632 Regulation of epithelial cell migration
Process GO:0010634 Positive regulation of epithelial cell migration
Process GO:0010941 Regulation of cell death
Process GO:0010942 Positive regulation of cell death
Process GO:0010959 Regulation of metal ion transport
Process GO:0014070 Response to organic cyclic compound
Process GO:0014074 Response to purine-containing compound
Process GO:0014738 Regulation of muscle hyperplasia
Process GO:0014740 Negative regulation of muscle hyperplasia
Process GO:0014745 Negative regulation of muscle adaptation
Process GO:0014805 Smooth muscle adaptation
Process GO:0014806 Smooth muscle hyperplasia
Process GO:0014823 Response to activity
Process GO:0014900 Muscle hyperplasia
Process GO:0016054 Organic acid catabolic process
Process GO:0016477 Cell migration
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019220 Regulation of phosphate metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019430 Removal of superoxide radicals
Process GO:0019752 Carboxylic acid metabolic process
Process GO:0019932 Second-messenger-mediated signaling
Process GO:0019953 Sexual reproduction
Process GO:0022414 Reproductive process
Process GO:0022602 Ovulation cycle process
Process GO:0022603 Regulation of anatomical structure morphogenesis
Process GO:0023052 Signaling
Process GO:0030001 Metal ion transport
Process GO:0030323 Respiratory tube development
Process GO:0030324 Lung development
Process GO:0030334 Regulation of cell migration
Process GO:0030335 Positive regulation of cell migration
Process GO:0030728 Ovulation
Process GO:0030808 Regulation of nucleotide biosynthetic process
Process GO:0030810 Positive regulation of nucleotide biosynthetic process
Process GO:0031279 Regulation of cyclase activity
Process GO:0031281 Positive regulation of cyclase activity
Process GO:0031282 Regulation of guanylate cyclase activity
Process GO:0031284 Positive regulation of guanylate cyclase activity
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031326 Regulation of cellular biosynthetic process
Process GO:0031328 Positive regulation of cellular biosynthetic process
Process GO:0031644 Regulation of nervous system process
Process GO:0031663 Lipopolysaccharide-mediated signaling pathway
Process GO:0031667 Response to nutrient levels
Process GO:0031960 Response to corticosteroid
Process GO:0032026 Response to magnesium ion
Process GO:0032355 Response to estradiol
Process GO:0032496 Response to lipopolysaccharide
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032504 Multicellular organism reproduction
Process GO:0032868 Response to insulin
Process GO:0032869 Cellular response to insulin stimulus
Process GO:0032870 Cellular response to hormone stimulus
Process GO:0032879 Regulation of localization
Process GO:0033554 Cellular response to stress
Process GO:0033993 Response to lipid
Process GO:0034097 Response to cytokine
Process GO:0034284 Response to monosaccharide
Process GO:0034405 Response to fluid shear stress
Process GO:0034599 Cellular response to oxidative stress
Process GO:0034605 Cellular response to heat
Process GO:0034612 Response to tumor necrosis factor
Process GO:0034614 Cellular response to reactive oxygen species
Process GO:0034641 Cellular nitrogen compound metabolic process
Process GO:0035094 Response to nicotine
Process GO:0035150 Regulation of tube size
Process GO:0035239 Tube morphogenesis
Process GO:0035295 Tube development
Process GO:0035296 Regulation of tube diameter
Process GO:0035556 Intracellular signal transduction
Process GO:0036017 Response to erythropoietin
Process GO:0036293 Response to decreased oxygen levels
Process GO:0036296 Response to increased oxygen levels
Process GO:0040012 Regulation of locomotion
Process GO:0040017 Positive regulation of locomotion
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042221 Response to chemical
Process GO:0042592 Homeostatic process
Process GO:0042698 Ovulation cycle
Process GO:0042981 Regulation of apoptotic process
Process GO:0043009 Chordate embryonic development
Process GO:0043010 Camera-type eye development
Process GO:0043065 Positive regulation of apoptotic process
Process GO:0043067 Regulation of programmed cell death
Process GO:0043068 Positive regulation of programmed cell death
Process GO:0043085 Positive regulation of catalytic activity
Process GO:0043086 Negative regulation of catalytic activity
Process GO:0043200 Response to amino acid
Process GO:0043207 Response to external biotic stimulus
Process GO:0043266 Regulation of potassium ion transport
Process GO:0043267 Negative regulation of potassium ion transport
Process GO:0043269 Regulation of ion transport
Process GO:0043271 Negative regulation of ion transport
Process GO:0043434 Response to peptide hormone
Process GO:0043436 Oxoacid metabolic process
Process GO:0043500 Muscle adaptation
Process GO:0043502 Regulation of muscle adaptation
Process GO:0043535 Regulation of blood vessel endothelial cell migration
Process GO:0043536 Positive regulation of blood vessel endothelial cell migration
Process GO:0043542 Endothelial cell migration
Process GO:0044057 Regulation of system process
Process GO:0044092 Negative regulation of molecular function
Process GO:0044093 Positive regulation of molecular function
Process GO:0044237 Cellular metabolic process
Process GO:0044238 Primary metabolic process
Process GO:0044248 Cellular catabolic process
Process GO:0044249 Cellular biosynthetic process
Process GO:0044271 Cellular nitrogen compound biosynthetic process
Process GO:0044281 Small molecule metabolic process
Process GO:0044282 Small molecule catabolic process
Process GO:0044419 Biological process involved in interspecies interaction between organisms
Process GO:0044703 Multi-organism reproductive process
Process GO:0044706 Multi-multicellular organism process
Process GO:0045137 Development of primary sexual characteristics
Process GO:0045471 Response to ethanol
Process GO:0045765 Regulation of angiogenesis
Process GO:0045766 Positive regulation of angiogenesis
Process GO:0045776 Negative regulation of blood pressure
Process GO:0045935 Positive regulation of nucleobase-containing compound metabolic process
Process GO:0045937 Positive regulation of phosphate metabolic process
Process GO:0045981 Positive regulation of nucleotide metabolic process
Process GO:0046209 Nitric oxide metabolic process
Process GO:0046395 Carboxylic acid catabolic process
Process GO:0046545 Development of primary female sexual characteristics
Process GO:0046660 Female sex differentiation
Process GO:0046683 Response to organophosphorus
Process GO:0046689 Response to mercury ion
Process GO:0048511 Rhythmic process
Process GO:0048513 Animal organ development
Process GO:0048514 Blood vessel morphogenesis
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048545 Response to steroid hormone
Process GO:0048583 Regulation of response to stimulus
Process GO:0048585 Negative regulation of response to stimulus
Process GO:0048608 Reproductive structure development
Process GO:0048609 Multicellular organismal reproductive process
Process GO:0048646 Anatomical structure formation involved in morphogenesis
Process GO:0048660 Regulation of smooth muscle cell proliferation
Process GO:0048662 Negative regulation of smooth muscle cell proliferation
Process GO:0048678 Response to axon injury
Process GO:0048729 Tissue morphogenesis
Process GO:0048731 System development
Process GO:0048771 Tissue remodeling
Process GO:0048856 Anatomical structure development
Process GO:0048870 Cell motility
Process GO:0048871 Multicellular organismal homeostasis
Process GO:0048872 Homeostasis of number of cells
Process GO:0048873 Homeostasis of number of cells within a tissue
Process GO:0048880 Sensory system development
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050886 Endocrine process
Process GO:0050896 Response to stimulus
Process GO:0051049 Regulation of transport
Process GO:0051051 Negative regulation of transport
Process GO:0051093 Negative regulation of developmental process
Process GO:0051094 Positive regulation of developmental process
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051174 Regulation of phosphorus metabolic process
Process GO:0051179 Localization
Process GO:0051234 Establishment of localization
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051240 Positive regulation of multicellular organismal process
Process GO:0051241 Negative regulation of multicellular organismal process
Process GO:0051336 Regulation of hydrolase activity
Process GO:0051339 Regulation of lyase activity
Process GO:0051346 Negative regulation of hydrolase activity
Process GO:0051349 Positive regulation of lyase activity
Process GO:0051384 Response to glucocorticoid
Process GO:0051385 Response to mineralocorticoid
Process GO:0051412 Response to corticosterone
Process GO:0051591 Response to cAMP
Process GO:0051641 Cellular localization
Process GO:0051649 Establishment of localization in cell
Process GO:0051707 Response to other organism
Process GO:0051716 Cellular response to stimulus
Process GO:0051924 Regulation of calcium ion transport
Process GO:0051926 Negative regulation of calcium ion transport
Process GO:0055093 Response to hyperoxia
Process GO:0055094 Response to lipoprotein particle
Process GO:0060041 Retina development in camera-type eye
Process GO:0060249 Anatomical structure homeostasis
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060348 Bone development
Process GO:0060411 Cardiac septum morphogenesis
Process GO:0060412 Ventricular septum morphogenesis
Process GO:0060485 Mesenchyme development
Process GO:0060541 Respiratory system development
Process GO:0061458 Reproductive system development
Process GO:0062012 Regulation of small molecule metabolic process
Process GO:0062013 Positive regulation of small molecule metabolic process
Process GO:0062197 Cellular response to chemical stress
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070167 Regulation of biomineral tissue development
Process GO:0070168 Negative regulation of biomineral tissue development
Process GO:0070482 Response to oxygen levels
Process GO:0070848 Response to growth factor
Process GO:0070887 Cellular response to chemical stimulus
Process GO:0071000 Response to magnetism
Process GO:0071214 Cellular response to abiotic stimulus
Process GO:0071216 Cellular response to biotic stimulus
Process GO:0071219 Cellular response to molecule of bacterial origin
Process GO:0071222 Cellular response to lipopolysaccharide
Process GO:0071241 Cellular response to inorganic substance
Process GO:0071248 Cellular response to metal ion
Process GO:0071260 Cellular response to mechanical stimulus
Process GO:0071286 Cellular response to magnesium ion
Process GO:0071310 Cellular response to organic substance
Process GO:0071320 Cellular response to cAMP
Process GO:0071345 Cellular response to cytokine stimulus
Process GO:0071356 Cellular response to tumor necrosis factor
Process GO:0071363 Cellular response to growth factor stimulus
Process GO:0071375 Cellular response to peptide hormone stimulus
Process GO:0071396 Cellular response to lipid
Process GO:0071402 Cellular response to lipoprotein particle stimulus
Process GO:0071403 Cellular response to high density lipoprotein particle stimulus
Process GO:0071404 Cellular response to low-density lipoprotein particle stimulus
Process GO:0071407 Cellular response to organic cyclic compound
Process GO:0071417 Cellular response to organonitrogen compound
Process GO:0071450 Cellular response to oxygen radical
Process GO:0071451 Cellular response to superoxide
Process GO:0071495 Cellular response to endogenous stimulus
Process GO:0071496 Cellular response to external stimulus
Process GO:0071559 Response to transforming growth factor beta
Process GO:0071560 Cellular response to transforming growth factor beta stimulus
Process GO:0071704 Organic substance metabolic process
Process GO:0072132 Mesenchyme morphogenesis
Process GO:0072359 Circulatory system development
Process GO:0072593 Reactive oxygen species metabolic process
Process GO:0080090 Regulation of primary metabolic process
Process GO:0090066 Regulation of anatomical structure size
Process GO:0090130 Tissue migration
Process GO:0090132 Epithelium migration
Process GO:0090257 Regulation of muscle system process
Process GO:0097237 Cellular response to toxic substance
Process GO:0097305 Response to alcohol
Process GO:0097746 Blood vessel diameter maintenance
Process GO:0098754 Detoxification
Process GO:0098869 Cellular oxidant detoxification
Process GO:0104004 Cellular response to environmental stimulus
Process GO:0110149 Regulation of biomineralization
Process GO:0110150 Negative regulation of biomineralization
Process GO:0150063 Visual system development
Process GO:1900371 Regulation of purine nucleotide biosynthetic process
Process GO:1900373 Positive regulation of purine nucleotide biosynthetic process
Process GO:1900542 Regulation of purine nucleotide metabolic process
Process GO:1900544 Positive regulation of purine nucleotide metabolic process
Process GO:1901342 Regulation of vasculature development
Process GO:1901556 Response to candesartan
Process GO:1901558 Response to metformin
Process GO:1901564 Organonitrogen compound metabolic process
Process GO:1901565 Organonitrogen compound catabolic process
Process GO:1901575 Organic substance catabolic process
Process GO:1901605 Alpha-amino acid metabolic process
Process GO:1901606 Alpha-amino acid catabolic process
Process GO:1901652 Response to peptide
Process GO:1901653 Cellular response to peptide
Process GO:1901654 Response to ketone
Process GO:1901655 Cellular response to ketone
Process GO:1901698 Response to nitrogen compound
Process GO:1901699 Cellular response to nitrogen compound
Process GO:1901700 Response to oxygen-containing compound
Process GO:1901701 Cellular response to oxygen-containing compound
Process GO:1902074 Response to salt
Process GO:1903522 Regulation of blood circulation
Process GO:1903576 Response to L-arginine
Process GO:1904018 Positive regulation of vasculature development
Process GO:1904647 Response to rotenone
Process GO:1904648 Cellular response to rotenone
Process GO:1905314 Semi-lunar valve development
Process GO:1990478 Response to ultrasound
Process GO:1990748 Cellular detoxification
Process GO:2000026 Regulation of multicellular organismal development
Process GO:2000145 Regulation of cell motility
Process GO:2000147 Positive regulation of cell motility
Process GO:2001057 Reactive nitrogen species metabolic process
Component GO:0005622 Intracellular anatomical structure
Component GO:0005634 Nucleus
Component GO:0005730 Nucleolus
Component GO:0005737 Cytoplasm
Component GO:0005739 Mitochondrion
Component GO:0005794 Golgi apparatus
Component GO:0005829 Cytosol
Component GO:0005856 Cytoskeleton
Component GO:0005886 Plasma membrane
Component GO:0005901 Caveola
Component GO:0012505 Endomembrane system
Component GO:0012506 Vesicle membrane
Component GO:0016020 Membrane
Component GO:0031090 Organelle membrane
Component GO:0031974 Membrane-enclosed lumen
Component GO:0031981 Nuclear lumen
Component GO:0031982 Vesicle
Component GO:0042383 Sarcolemma
Component GO:0043226 Organelle
Component GO:0043227 Membrane-bounded organelle
Component GO:0043228 Non-membrane-bounded organelle
Component GO:0043229 Intracellular organelle
Component GO:0043231 Intracellular membrane-bounded organelle
Component GO:0043232 Intracellular non-membrane-bounded organelle
Component GO:0043233 Organelle lumen
Component GO:0044853 Plasma membrane raft
Component GO:0045121 Membrane raft
Component GO:0045177 Apical part of cell
Component GO:0070013 Intracellular organelle lumen
Component GO:0071944 Cell periphery
Component GO:0098590 Plasma membrane region
Component GO:0098857 Membrane microdomain
Component GO:0110165 Cellular anatomical entity
Function GO:0000166 Nucleotide binding
Function GO:0003779 Actin binding
Function GO:0003785 Actin monomer binding
Function GO:0003824 Catalytic activity
Function GO:0004497 Monooxygenase activity
Function GO:0004517 Nitric-oxide synthase activity
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0005516 Calmodulin binding
Function GO:0008013 Beta-catenin binding
Function GO:0008092 Cytoskeletal protein binding
Function GO:0010181 FMN binding
Function GO:0016491 Oxidoreductase activity
Function GO:0016597 Amino acid binding
Function GO:0016705 Oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
Function GO:0016709 Oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen
Function GO:0019899 Enzyme binding
Function GO:0020037 Heme binding
Function GO:0031072 Heat shock protein binding
Function GO:0031406 Carboxylic acid binding
Function GO:0032553 Ribonucleotide binding
Function GO:0034617 Tetrahydrobiopterin binding
Function GO:0034618 Arginine binding
Function GO:0036094 Small molecule binding
Function GO:0043167 Ion binding
Function GO:0043168 Anion binding
Function GO:0043169 Cation binding
Function GO:0043177 Organic acid binding
Function GO:0045296 Cadherin binding
Function GO:0046872 Metal ion binding
Function GO:0046906 Tetrapyrrole binding
Function GO:0050660 Flavin adenine dinucleotide binding
Function GO:0050661 NADP binding
Function GO:0050839 Cell adhesion molecule binding
Function GO:0050998 Nitric-oxide synthase binding
Function GO:0051879 Hsp90 protein binding
Function GO:0097110 Scaffold protein binding
Function GO:0097159 Organic cyclic compound binding
Function GO:0097367 Carbohydrate derivative binding
Function GO:1901265 Nucleoside phosphate binding
Function GO:1901363 Heterocyclic compound binding
Process GO:0000003 Reproduction
Process GO:0000302 Response to reactive oxygen species
Process GO:0000303 Response to superoxide
Process GO:0000305 Response to oxygen radical
Process GO:0001525 Angiogenesis
Process GO:0001542 Ovulation from ovarian follicle
Process GO:0001568 Blood vessel development
Process GO:0001667 Ameboidal-type cell migration
Process GO:0001701 In utero embryonic development
Process GO:0001894 Tissue homeostasis
Process GO:0001944 Vasculature development
Process GO:0001974 Blood vessel remodeling
Process GO:0001990 Regulation of systemic arterial blood pressure by hormone
Process GO:0002026 Regulation of the force of heart contraction
Process GO:0002028 Regulation of sodium ion transport
Process GO:0002237 Response to molecule of bacterial origin
Process GO:0003006 Developmental process involved in reproduction
Process GO:0003007 Heart morphogenesis
Process GO:0003008 System process
Process GO:0003012 Muscle system process
Process GO:0003013 Circulatory system process
Process GO:0003018 Vascular process in circulatory system
Process GO:0003044 Regulation of systemic arterial blood pressure mediated by a chemical signal
Process GO:0003057 Regulation of the force of heart contraction by chemical signal
Process GO:0003073 Regulation of systemic arterial blood pressure
Process GO:0003100 Regulation of systemic arterial blood pressure by endothelin
Process GO:0003170 Heart valve development
Process GO:0003176 Aortic valve development
Process GO:0003177 Pulmonary valve development
Process GO:0003179 Heart valve morphogenesis
Process GO:0003180 Aortic valve morphogenesis
Process GO:0003184 Pulmonary valve morphogenesis
Process GO:0003197 Endocardial cushion development
Process GO:0003203 Endocardial cushion morphogenesis
Process GO:0003205 Cardiac chamber development
Process GO:0003206 Cardiac chamber morphogenesis
Process GO:0003231 Cardiac ventricle development
Process GO:0003279 Cardiac septum development
Process GO:0003281 Ventricular septum development
Process GO:0006082 Organic acid metabolic process
Process GO:0006140 Regulation of nucleotide metabolic process
Process GO:0006520 Cellular amino acid metabolic process
Process GO:0006525 Arginine metabolic process
Process GO:0006527 Arginine catabolic process
Process GO:0006801 Superoxide metabolic process
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006809 Nitric oxide biosynthetic process
Process GO:0006810 Transport
Process GO:0006811 Ion transport
Process GO:0006812 Cation transport
Process GO:0006813 Potassium ion transport
Process GO:0006816 Calcium ion transport
Process GO:0006950 Response to stress
Process GO:0006979 Response to oxidative stress
Process GO:0007154 Cell communication
Process GO:0007165 Signal transduction
Process GO:0007166 Cell surface receptor signaling pathway
Process GO:0007263 Nitric oxide mediated signal transduction
Process GO:0007275 Multicellular organism development
Process GO:0007276 Gamete generation
Process GO:0007292 Female gamete generation
Process GO:0007507 Heart development
Process GO:0007548 Sex differentiation
Process GO:0008015 Blood circulation
Process GO:0008016 Regulation of heart contraction
Process GO:0008152 Metabolic process
Process GO:0008217 Regulation of blood pressure
Process GO:0008285 Negative regulation of cell population proliferation
Process GO:0008406 Gonad development
Process GO:0008585 Female gonad development
Process GO:0009056 Catabolic process
Process GO:0009058 Biosynthetic process
Process GO:0009063 Cellular amino acid catabolic process
Process GO:0009064 Glutamine family amino acid metabolic process
Process GO:0009065 Glutamine family amino acid catabolic process
Process GO:0009605 Response to external stimulus
Process GO:0009607 Response to biotic stimulus
Process GO:0009617 Response to bacterium
Process GO:0009628 Response to abiotic stimulus
Process GO:0009636 Response to toxic substance
Process GO:0009653 Anatomical structure morphogenesis
Process GO:0009719 Response to endogenous stimulus
Process GO:0009725 Response to hormone
Process GO:0009790 Embryo development
Process GO:0009792 Embryo development ending in birth or egg hatching
Process GO:0009887 Animal organ morphogenesis
Process GO:0009888 Tissue development
Process GO:0009889 Regulation of biosynthetic process
Process GO:0009891 Positive regulation of biosynthetic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009987 Cellular process
Process GO:0010033 Response to organic substance
Process GO:0010035 Response to inorganic substance
Process GO:0010468 Regulation of gene expression
Process GO:0010562 Positive regulation of phosphorus metabolic process
Process GO:0010594 Regulation of endothelial cell migration
Process GO:0010595 Positive regulation of endothelial cell migration
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010628 Positive regulation of gene expression
Process GO:0010631 Epithelial cell migration
Process GO:0010632 Regulation of epithelial cell migration
Process GO:0010634 Positive regulation of epithelial cell migration
Process GO:0010941 Regulation of cell death
Process GO:0010959 Regulation of metal ion transport
Process GO:0014738 Regulation of muscle hyperplasia
Process GO:0014745 Negative regulation of muscle adaptation
Process GO:0016054 Organic acid catabolic process
Process GO:0016477 Cell migration
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019220 Regulation of phosphate metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019430 Removal of superoxide radicals
Process GO:0019752 Carboxylic acid metabolic process
Process GO:0019932 Second-messenger-mediated signaling
Process GO:0019953 Sexual reproduction
Process GO:0022414 Reproductive process
Process GO:0022602 Ovulation cycle process
Process GO:0022603 Regulation of anatomical structure morphogenesis
Process GO:0023052 Signaling
Process GO:0030001 Metal ion transport
Process GO:0030323 Respiratory tube development
Process GO:0030324 Lung development
Process GO:0030334 Regulation of cell migration
Process GO:0030335 Positive regulation of cell migration
Process GO:0030728 Ovulation
Process GO:0030808 Regulation of nucleotide biosynthetic process
Process GO:0030810 Positive regulation of nucleotide biosynthetic process
Process GO:0031279 Regulation of cyclase activity
Process GO:0031281 Positive regulation of cyclase activity
Process GO:0031282 Regulation of guanylate cyclase activity
Process GO:0031284 Positive regulation of guanylate cyclase activity
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031326 Regulation of cellular biosynthetic process
Process GO:0031328 Positive regulation of cellular biosynthetic process
Process GO:0031644 Regulation of nervous system process
Process GO:0031663 Lipopolysaccharide-mediated signaling pathway
Process GO:0032496 Response to lipopolysaccharide
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032504 Multicellular organism reproduction
Process GO:0032879 Regulation of localization
Process GO:0033554 Cellular response to stress
Process GO:0033993 Response to lipid
Process GO:0034405 Response to fluid shear stress
Process GO:0034599 Cellular response to oxidative stress
Process GO:0034614 Cellular response to reactive oxygen species
Process GO:0034641 Cellular nitrogen compound metabolic process
Process GO:0035150 Regulation of tube size
Process GO:0035239 Tube morphogenesis
Process GO:0035295 Tube development
Process GO:0035296 Regulation of tube diameter
Process GO:0035556 Intracellular signal transduction
Process GO:0040012 Regulation of locomotion
Process GO:0040017 Positive regulation of locomotion
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042221 Response to chemical
Process GO:0042592 Homeostatic process
Process GO:0042698 Ovulation cycle
Process GO:0042981 Regulation of apoptotic process
Process GO:0043009 Chordate embryonic development
Process GO:0043067 Regulation of programmed cell death
Process GO:0043085 Positive regulation of catalytic activity
Process GO:0043086 Negative regulation of catalytic activity
Process GO:0043207 Response to external biotic stimulus
Process GO:0043266 Regulation of potassium ion transport
Process GO:0043267 Negative regulation of potassium ion transport
Process GO:0043269 Regulation of ion transport
Process GO:0043271 Negative regulation of ion transport
Process GO:0043436 Oxoacid metabolic process
Process GO:0043500 Muscle adaptation
Process GO:0043502 Regulation of muscle adaptation
Process GO:0043535 Regulation of blood vessel endothelial cell migration
Process GO:0043536 Positive regulation of blood vessel endothelial cell migration
Process GO:0043542 Endothelial cell migration
Process GO:0044057 Regulation of system process
Process GO:0044092 Negative regulation of molecular function
Process GO:0044093 Positive regulation of molecular function
Process GO:0044237 Cellular metabolic process
Process GO:0044238 Primary metabolic process
Process GO:0044248 Cellular catabolic process
Process GO:0044249 Cellular biosynthetic process
Process GO:0044271 Cellular nitrogen compound biosynthetic process
Process GO:0044281 Small molecule metabolic process
Process GO:0044282 Small molecule catabolic process
Process GO:0044419 Biological process involved in interspecies interaction between organisms
Process GO:0045137 Development of primary sexual characteristics
Process GO:0045765 Regulation of angiogenesis
Process GO:0045766 Positive regulation of angiogenesis
Process GO:0045776 Negative regulation of blood pressure
Process GO:0045935 Positive regulation of nucleobase-containing compound metabolic process
Process GO:0045937 Positive regulation of phosphate metabolic process
Process GO:0045981 Positive regulation of nucleotide metabolic process
Process GO:0046209 Nitric oxide metabolic process
Process GO:0046395 Carboxylic acid catabolic process
Process GO:0046545 Development of primary female sexual characteristics
Process GO:0046660 Female sex differentiation
Process GO:0048511 Rhythmic process
Process GO:0048513 Animal organ development
Process GO:0048514 Blood vessel morphogenesis
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048583 Regulation of response to stimulus
Process GO:0048585 Negative regulation of response to stimulus
Process GO:0048608 Reproductive structure development
Process GO:0048609 Multicellular organismal reproductive process
Process GO:0048646 Anatomical structure formation involved in morphogenesis
Process GO:0048660 Regulation of smooth muscle cell proliferation
Process GO:0048662 Negative regulation of smooth muscle cell proliferation
Process GO:0048729 Tissue morphogenesis
Process GO:0048731 System development
Process GO:0048771 Tissue remodeling
Process GO:0048856 Anatomical structure development
Process GO:0048870 Cell motility
Process GO:0048871 Multicellular organismal homeostasis
Process GO:0048872 Homeostasis of number of cells
Process GO:0048873 Homeostasis of number of cells within a tissue
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050886 Endocrine process
Process GO:0050896 Response to stimulus
Process GO:0051049 Regulation of transport
Process GO:0051051 Negative regulation of transport
Process GO:0051093 Negative regulation of developmental process
Process GO:0051094 Positive regulation of developmental process
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051174 Regulation of phosphorus metabolic process
Process GO:0051179 Localization
Process GO:0051234 Establishment of localization
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051240 Positive regulation of multicellular organismal process
Process GO:0051241 Negative regulation of multicellular organismal process
Process GO:0051336 Regulation of hydrolase activity
Process GO:0051339 Regulation of lyase activity
Process GO:0051346 Negative regulation of hydrolase activity
Process GO:0051349 Positive regulation of lyase activity
Process GO:0051641 Cellular localization
Process GO:0051649 Establishment of localization in cell
Process GO:0051707 Response to other organism
Process GO:0051716 Cellular response to stimulus
Process GO:0051924 Regulation of calcium ion transport
Process GO:0051926 Negative regulation of calcium ion transport
Process GO:0060249 Anatomical structure homeostasis
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060411 Cardiac septum morphogenesis
Process GO:0060412 Ventricular septum morphogenesis
Process GO:0060485 Mesenchyme development
Process GO:0060541 Respiratory system development
Process GO:0061458 Reproductive system development
Process GO:0062012 Regulation of small molecule metabolic process
Process GO:0062013 Positive regulation of small molecule metabolic process
Process GO:0062197 Cellular response to chemical stress
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070167 Regulation of biomineral tissue development
Process GO:0070168 Negative regulation of biomineral tissue development
Process GO:0070887 Cellular response to chemical stimulus
Process GO:0071216 Cellular response to biotic stimulus
Process GO:0071219 Cellular response to molecule of bacterial origin
Process GO:0071222 Cellular response to lipopolysaccharide
Process GO:0071310 Cellular response to organic substance
Process GO:0071396 Cellular response to lipid
Process GO:0071450 Cellular response to oxygen radical
Process GO:0071451 Cellular response to superoxide
Process GO:0071704 Organic substance metabolic process
Process GO:0072132 Mesenchyme morphogenesis
Process GO:0072359 Circulatory system development
Process GO:0072593 Reactive oxygen species metabolic process
Process GO:0080090 Regulation of primary metabolic process
Process GO:0090066 Regulation of anatomical structure size
Process GO:0090130 Tissue migration
Process GO:0090132 Epithelium migration
Process GO:0090257 Regulation of muscle system process
Process GO:0097237 Cellular response to toxic substance
Process GO:0097746 Blood vessel diameter maintenance
Process GO:0098754 Detoxification
Process GO:0098869 Cellular oxidant detoxification
Process GO:0110149 Regulation of biomineralization
Process GO:0110150 Negative regulation of biomineralization
Process GO:1900371 Regulation of purine nucleotide biosynthetic process
Process GO:1900373 Positive regulation of purine nucleotide biosynthetic process
Process GO:1900542 Regulation of purine nucleotide metabolic process
Process GO:1900544 Positive regulation of purine nucleotide metabolic process
Process GO:1901342 Regulation of vasculature development
Process GO:1901564 Organonitrogen compound metabolic process
Process GO:1901565 Organonitrogen compound catabolic process
Process GO:1901575 Organic substance catabolic process
Process GO:1901605 Alpha-amino acid metabolic process
Process GO:1901606 Alpha-amino acid catabolic process
Process GO:1901700 Response to oxygen-containing compound
Process GO:1901701 Cellular response to oxygen-containing compound
Process GO:1903522 Regulation of blood circulation
Process GO:1904018 Positive regulation of vasculature development
Process GO:1905314 Semi-lunar valve development
Process GO:1990748 Cellular detoxification
Process GO:2000026 Regulation of multicellular organismal development
Process GO:2000145 Regulation of cell motility
Process GO:2000147 Positive regulation of cell motility
Process GO:2001057 Reactive nitrogen species metabolic process
Process GO:0014740 Negative regulation of muscle hyperplasia
Process GO:0014805 Smooth muscle adaptation
Process GO:0014806 Smooth muscle hyperplasia
Process GO:0014900 Muscle hyperplasia
Component GO:0005622 Intracellular anatomical structure
Component GO:0005634 Nucleus
Component GO:0005737 Cytoplasm
Component GO:0005794 Golgi apparatus
Component GO:0005829 Cytosol
Component GO:0005856 Cytoskeleton
Component GO:0005886 Plasma membrane
Component GO:0005901 Caveola
Component GO:0012505 Endomembrane system
Component GO:0012506 Vesicle membrane
Component GO:0016020 Membrane
Component GO:0031090 Organelle membrane
Component GO:0031982 Vesicle
Component GO:0043226 Organelle
Component GO:0043227 Membrane-bounded organelle
Component GO:0043228 Non-membrane-bounded organelle
Component GO:0043229 Intracellular organelle
Component GO:0043231 Intracellular membrane-bounded organelle
Component GO:0043232 Intracellular non-membrane-bounded organelle
Component GO:0044853 Plasma membrane raft
Component GO:0045121 Membrane raft
Component GO:0071944 Cell periphery
Component GO:0098590 Plasma membrane region
Component GO:0098857 Membrane microdomain
Component GO:0110165 Cellular anatomical entity
Function GO:0000166 Nucleotide binding
Function GO:0003779 Actin binding
Function GO:0003785 Actin monomer binding
Function GO:0003824 Catalytic activity
Function GO:0004497 Monooxygenase activity
Function GO:0004517 Nitric-oxide synthase activity
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0005516 Calmodulin binding
Function GO:0008092 Cytoskeletal protein binding
Function GO:0010181 FMN binding
Function GO:0016491 Oxidoreductase activity
Function GO:0016597 Amino acid binding
Function GO:0016705 Oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
Function GO:0016709 Oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen
Function GO:0020037 Heme binding
Function GO:0031406 Carboxylic acid binding
Function GO:0032553 Ribonucleotide binding
Function GO:0034617 Tetrahydrobiopterin binding
Function GO:0034618 Arginine binding
Function GO:0036094 Small molecule binding
Function GO:0043167 Ion binding
Function GO:0043168 Anion binding
Function GO:0043169 Cation binding
Function GO:0043177 Organic acid binding
Function GO:0046872 Metal ion binding
Function GO:0046906 Tetrapyrrole binding
Function GO:0050660 Flavin adenine dinucleotide binding
Function GO:0050661 NADP binding
Function GO:0097110 Scaffold protein binding
Function GO:0097159 Organic cyclic compound binding
Function GO:0097367 Carbohydrate derivative binding
Function GO:1901265 Nucleoside phosphate binding
Function GO:1901363 Heterocyclic compound binding

Pathway annotation


Category Term ID Term description
RCTM RNO-109582 Hemostasis
RCTM RNO-1222556 ROS and RNS production in phagocytes
RCTM RNO-1430728 Metabolism
RCTM RNO-1474151 Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
RCTM RNO-162582 Signal Transduction
RCTM RNO-168249 Innate Immune System
RCTM RNO-168256 Immune System
RCTM RNO-194138 Signaling by VEGF
RCTM RNO-196854 Metabolism of vitamins and cofactors
RCTM RNO-202131 Metabolism of nitric oxide: NOS3 activation and regulation
RCTM RNO-203615 eNOS activation
RCTM RNO-203641 NOSTRIN mediated eNOS trafficking
RCTM RNO-203754 NOSIP mediated eNOS trafficking
RCTM RNO-392154 Nitric oxide stimulates guanylate cyclase
RCTM RNO-418346 Platelet homeostasis
RCTM RNO-4420097 VEGFA-VEGFR2 Pathway
RCTM RNO-5218920 VEGFR2 mediated vascular permeability
RCTM RNO-8939211 ESR-mediated signaling
RCTM RNO-8978934 Metabolism of cofactors
RCTM RNO-9006931 Signaling by Nuclear Receptors
RCTM RNO-9006934 Signaling by Receptor Tyrosine Kinases
RCTM RNO-9009391 Extra-nuclear estrogen signaling
WikiPathways WP140 Myometrial relaxation and contraction pathways
WikiPathways WP1964 VEGFR-3 signaling
WikiPathways WP1965 VEGF-receptor signal transduction
WikiPathways WP3887 Angiotensin II signaling (acute) in thick ascending limbs
WikiPathways WP557 ACE inhibitor pathway
RCTM MAP-109582 Hemostasis
RCTM MAP-1222556 ROS and RNS production in phagocytes
RCTM MAP-1430728 Metabolism
RCTM MAP-1474151 Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
RCTM MAP-162582 Signal Transduction
RCTM MAP-168249 Innate Immune System
RCTM MAP-168256 Immune System
RCTM MAP-194138 Signaling by VEGF
RCTM MAP-196854 Metabolism of vitamins and cofactors
RCTM MAP-202131 Metabolism of nitric oxide: NOS3 activation and regulation
RCTM MAP-203615 eNOS activation
RCTM MAP-203641 NOSTRIN mediated eNOS trafficking
RCTM MAP-203754 NOSIP mediated eNOS trafficking
RCTM MAP-392154 Nitric oxide stimulates guanylate cyclase
RCTM MAP-418346 Platelet homeostasis
RCTM MAP-4420097 VEGFA-VEGFR2 Pathway
RCTM MAP-5218920 VEGFR2 mediated vascular permeability
RCTM MAP-8939211 ESR-mediated signaling
RCTM MAP-8978934 Metabolism of cofactors
RCTM MAP-9006931 Signaling by Nuclear Receptors
RCTM MAP-9006934 Signaling by Receptor Tyrosine Kinases
RCTM MAP-9009391 Extra-nuclear estrogen signaling
KEGG ocu00220 Arginine biosynthesis
KEGG ocu00330 Arginine and proline metabolism
KEGG ocu01100 Metabolic pathways
KEGG ocu04020 Calcium signaling pathway
KEGG ocu04022 cGMP-PKG signaling pathway
KEGG ocu04066 HIF-1 signaling pathway
KEGG ocu04071 Sphingolipid signaling pathway
KEGG ocu04151 PI3K-Akt signaling pathway
KEGG ocu04370 VEGF signaling pathway
KEGG ocu04371 Apelin signaling pathway
KEGG ocu04611 Platelet activation
KEGG ocu04915 Estrogen signaling pathway
KEGG ocu04921 Oxytocin signaling pathway
KEGG ocu04926 Relaxin signaling pathway
KEGG ocu04931 Insulin resistance
KEGG ocu04933 AGE-RAGE signaling pathway in diabetic complications
KEGG ocu05415 Diabetic cardiomyopathy
KEGG ocu05417 Lipid and atherosclerosis
KEGG ocu05418 Fluid shear stress and atherosclerosis
KEGG rno00220 Arginine biosynthesis
KEGG rno00330 Arginine and proline metabolism
KEGG rno01100 Metabolic pathways
KEGG rno04020 Calcium signaling pathway
KEGG rno04022 cGMP-PKG signaling pathway
KEGG rno04066 HIF-1 signaling pathway
KEGG rno04071 Sphingolipid signaling pathway
KEGG rno04151 PI3K-Akt signaling pathway
KEGG rno04370 VEGF signaling pathway
KEGG rno04371 Apelin signaling pathway
KEGG rno04611 Platelet activation
KEGG rno04915 Estrogen signaling pathway
KEGG rno04921 Oxytocin signaling pathway
KEGG rno04926 Relaxin signaling pathway
KEGG rno04931 Insulin resistance
KEGG rno04933 AGE-RAGE signaling pathway in diabetic complications
KEGG rno05415 Diabetic cardiomyopathy
KEGG rno05417 Lipid and atherosclerosis
KEGG rno05418 Fluid shear stress and atherosclerosis

Expression profile of Nos3 in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 8.935863
GSM2685202 MX2 tissue: Myocardium gender: female 9.367597
GSM2685203 MX3 tissue: Myocardium gender: female 9.466304
GSM2685204 MX4 tissue: Myocardium gender: male 9.461864
GSM2685205 DZ1 tissue: Myocardium gender: male 9.664716
GSM2685206 DZ2 tissue: Myocardium gender: male 9.725143
GSM2685207 DZ3 tissue: Myocardium gender: female 9.625668
GSM2685208 DZ4 tissue: Myocardium gender: female 9.495995
GSM2685209 JJ1 tissue: Myocardium gender: male 9.755312
GSM2685210 JJ2 tissue: Myocardium gender: female 8.329498
GSM2685211 JJ3 tissue: Myocardium gender: female 9.078106
GSM2685212 JJ4 tissue: Myocardium gender: male 8.669154
GSM2685213 NG1 tissue: Myocardium gender: male 8.582897
GSM2685214 NG2 tissue: Myocardium gender: female 9.335518
GSM2685215 NG3 tissue: Myocardium gender: male 9.417192
GSM2685216 NG4 tissue: Myocardium gender: female 9.201997
GSM2685217 YL1 tissue: Myocardium gender: male 8.817455
GSM2685218 YL2 tissue: Myocardium gender: male 9.303521
GSM2685219 YL3 tissue: Myocardium gender: female 9.753256
GSM2685220 YL4 tissue: Myocardium gender: female 9.85553
GSM2685221 QC1 tissue: Myocardium gender: male 8.543994
GSM2685222 QC2 tissue: Myocardium gender: male 8.115706
GSM2685223 QC3 tissue: Myocardium gender: female 8.978497
GSM2685224 QC4 tissue: Myocardium gender: female 9.310518

ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.577309664
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.59461684
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.589952487
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.062948786
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.898933884
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.738523862

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 323.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 211.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 288.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 340.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 231.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 235.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 234.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 546.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 180.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 326.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 210.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 438.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 111.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 150.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 131.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 179.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.347282
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.455225
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.463161
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.606565
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.405693
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.404594

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 6.449
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 6.225
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 8.456
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 5.529
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 5.176

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 6.352259455
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 5.738114204
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 5.739980333

ID GSE1616
Title Genomics of preconditioning
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM27484 APC_a (anesthetic-preconditioning, 1st replicate) 317.6166666666667
GSM27485 APC_b (anesthetic-preconditioning, 2nd replicate) 393.45
GSM27486 APC_c (anesthetic-preconditioning, 3rd replicate) 287.01666666666665
GSM27487 APC_d (anesthetic-preconditioning, 4th replicate) 244.41666666666666
GSM27488 APC_e (anesthetic-preconditioning, 5th replicate) 204.38333333333333
GSM27489 APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) 201.61666666666667
GSM27490 APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) 155.41666666666666
GSM27491 APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) 143.65
GSM27492 APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) 190.9
GSM27493 APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) 179.35
GSM27494 CTL_a (control, 1st replicate) 195.28333333333333
GSM27495 CTL_b (control, 2nd replicate) 167.83333333333334
GSM27496 CTL_c (control, 3rd replicate) 294.95
GSM27497 CTL_d (control, 4th replicate) 301.4166666666667
GSM27498 CTL_e (control, 5th replicate) 307.03333333333336
GSM27499 IPC_a (ischemic preconditioning, 1st replicate) 256.85
GSM27500 IPC_b (ischemic preconditioning, 2nd replicate) 245.48333333333335
GSM27501 IPC_c (ischemic preconditioning, 3rd replicate) 361.40000000000003
GSM27502 IPC_d (ischemic preconditioning, 4th replicate) 280.9166666666667
GSM27503 IPC_e (ischemic preconditioning, 5th replicate) 352.2
GSM27504 IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) 187.6833333333333
GSM27505 IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) 170.41666666666666
GSM27506 IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) 244.73333333333335
GSM27507 IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) 326.5833333333333
GSM27508 IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) 238.46666666666667
GSM27509 ISCH_a (ischemia, 1st replicate) 420.1666666666667
GSM27510 ISCH_b (ischemia, 2nd replicate) 310.56666666666666
GSM27511 ISCH_c (ischemia, 3rd replicate) 369.81666666666666
GSM27512 ISCH_d (ischemia, 4th replicate) 541.8333333333334
GSM27513 ISCH_e (ischemia, 5th replicate) 351.6666666666667

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 56.6
GSM30791 baseline control 02 male, 275-300g 21.6
GSM30792 baseline control 03 male, 275-300g 10.0
GSM30793 baseline control 04 male, 275-300g 4.0
GSM30794 baseline control 05 male, 275-300g 52.2
GSM30795 baseline control 06 male, 275-300g 5.5
GSM30796 baseline control 07 male, 275-300g 12.3
GSM30797 baseline control 08 male, 275-300g 4.2
GSM30798 baseline control 09 male, 275-300g 6.7
GSM30799 pain 01 51.6
GSM30800 pain 02 9.3
GSM30801 pain 03 100.0
GSM30802 pain 04 7.8
GSM30803 pain 05 13.5
GSM30804 FC 01 56.3
GSM30805 FC 02 27.3
GSM30806 FC 03 33.4
GSM30807 FC 04 19.0
GSM30808 FC 05 45.8
GSM30809 IFC 01 42.0
GSM30810 IFC 02 22.9
GSM30811 IFC 03 52.5
GSM30812 IFC 04 8.3
GSM30813 IFC 05 35.4
GSM99800 isoflurane 01 male, 275-300g 15.0
GSM99801 isoflurane 02 male, 275-300g 43.6
GSM99802 isoflurane 03 male, 275-300g 29.9
GSM99803 isoflurane 04 male, 275-300g 26.5
GSM99804 isoflurane 05 male, 275-300g 34.9

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 8.8737
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 16.6961
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 12.1981
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 15.5282
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 11.0294
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 13.39
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 11.8902
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 13.8516
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 12.6969

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 3.78931
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 4.34552
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 4.33273
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 4.65769
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 4.04329
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 4.33661
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 4.09682
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 4.9654
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 4.26216
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 5.11155
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 3.67516
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 3.83275
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 4.68888
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 4.11696
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 4.65881
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 4.67314

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 4.89019
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 4.946383
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.57159
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.212712
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.12031
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.815161
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.240783
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.15353
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.610558
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.00665
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.110214
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.076183
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.535554
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.086522
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 4.963826
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.193502
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.618007
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.174562
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 4.866371
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.424795
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.578552
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.257483
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.120162
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.388796
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.325343
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.034262
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.124672
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 4.894838
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 4.84309
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 4.955371
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.083275
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 4.938885
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.387093
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 4.992702
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 4.818079
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 4.861666
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.625268
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 4.690618
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.486077
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.289441
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.030786
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 4.981105
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.52537
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.064855
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 4.944378

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 25.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 29.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 56.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 32.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 33.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 59.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 47.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 32.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 42.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 50.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 26.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 37.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 47.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 41.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 46.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 37.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 40.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 32.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 38.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 46.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 30.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 46.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 41.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 55.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 43.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 31.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 57.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 45.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 63.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 24.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 57.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 35.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 39.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 60.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 38.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 37.0

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 3.588727
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 3.560413
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 2.526699
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 4.513535

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; -0.0135
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 -0.0788
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 -0.000373
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 0.265
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 -0.02
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 -0.0571
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 -0.0451
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 -0.0455
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 -0.0381
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 0.000952
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 -0.0376
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 -0.0683

ID GSE359
Title Isoflurane Single Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5120 Isoflurane single exposure control-1 48.65
GSM5121 Isoflurane single exposure control-2 42.400000000000006
GSM5122 Isoflurane single exposure control-3 42.916666666666664
GSM5124 Isoflurane single exposure 1 hr-1 44.81666666666666
GSM5126 Isoflurane single exposure 1 hr-2 39.300000000000004
GSM5127 Isoflurane single exposure 2 hr-1 53.65
GSM5130 Isoflurane single exposure 2 hr-2 58.949999999999996
GSM5131 Isoflurane single exposure 2 hr-3 41.300000000000004

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.293972622
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.002690766
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.000876274
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.318799014
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.250199972
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.376250675
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.27359475
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.234594938
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.245837265
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.22431477
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.494098841
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.130769034
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 2.98361917
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 3.04742998
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.099382152
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.178772969
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 3.004213546
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 3.134621138
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.433903456
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.406336243
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.342129047
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 2.927873187
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.236570832
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.197695442

ID GSE53897
Title Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1303240 DRG RVM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.972056
GSM1303241 DRG RVM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.46016
GSM1303242 DRG RVM3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.985533
GSM1303243 DRG RVM7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.092381
GSM1303244 DRG RVOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.962603
GSM1303245 DRG RVOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.760306
GSM1303246 DRG RVOx5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.894989
GSM1303247 DRG RVOx7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.467026
GSM1303248 DRG RVS4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.39635
GSM1303249 DRG RVS5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.631155
GSM1303250 DRG RVS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.778577
GSM1303251 DRG RVS7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.272361
GSM1303252 DRG RSM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.16508
GSM1303253 DRG RSM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.890012
GSM1303254 DRG RSM4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.774944
GSM1303255 DRG RSM5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.38523
GSM1303256 DRG RSOx1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.374261
GSM1303257 DRG RSOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.569316
GSM1303258 DRG RSOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.283242
GSM1303259 DRG RSOx4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.547964
GSM1303260 DRG RSS1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.594904
GSM1303261 DRG RSS2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.64142
GSM1303262 DRG RSS3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.534926
GSM1303263 DRG RSS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.341955

ID GSE55573
Title Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1339443 Mock skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 226.4234
GSM1339444 EA (electroacupuncture) skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 311.9637

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 7.253264746
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 1.283579146
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 49.78131295
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 13.33007914
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 29.58980958
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 48.37488055
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 21.69948136
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 10.99036894
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 21.58889449
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 6.169663111
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 41.77779856
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 13.63153577
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 10.54424475
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 14.40974569

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.293972622
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.002690766
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.000876274
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.318799014
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.250199972
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.376250675
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.27359475
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.234594938
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.245837265
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.22431477
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.494098841
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.130769034
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 2.98361917
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 3.04742998
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.099382152
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.178772969
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 3.004213546
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 3.134621138
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.433903456
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.406336243
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.342129047
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 2.927873187
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.236570832
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.197695442
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 7.253264746
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 1.283579146
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 49.78131295
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 13.33007914
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 29.58980958
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 48.37488055
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 21.69948136
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 10.99036894
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 21.58889449
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 6.169663111
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 41.77779856
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 13.63153577
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 10.54424475
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 14.40974569

ID GSE752
Title Halothane/Isoflurane Repetitive Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5082 Control 1 79.5
GSM5084 Control 2 81.14999999999999
GSM5085 Control 3 75.01666666666667
GSM5086 Control 4 91.25
GSM5087 Control 5 76.05
GSM5090 Control 6 94.13333333333334
GSM5105 Control 7 77.23333333333333
GSM5106 Control 8 87.11666666666667
GSM5107 Control 9 81.56666666666666
GSM5108 Halothane 10 exposure-1 60.883333333333326
GSM5109 Halothane 10 exposures-2 68.60000000000001
GSM5110 Halothane 10 exposures-3 51.166666666666664
GSM5111 Halothane 5 exposures-1 68.98333333333333
GSM5112 Halothane 5 exposures-2 68.39999999999999
GSM5113 Halothane 5 exposures-3 74.18333333333332
GSM5114 Isoflurane 10 exposures-1 54.449999999999996
GSM5115 Isoflurane 10 exposures-2 55.48333333333333
GSM5116 Isoflurane 10 exposures-3 56.616666666666674
GSM5117 Isoflurane 5 exposures-1 75.49999999999999
GSM5118 Isoflurane 5 exposures-2 89.96666666666665
GSM5119 Isoflurane 5 exposures-3 66.51666666666667
GSM11379 Control 10 65.81666666666668
GSM11380 Control 11 53.916666666666664
GSM11381 Control 12 74.45

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 13.6381
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 31.269